10D1F, an Anti-HER3 Antibody that Uniquely Blocks the Receptor Heterodimerization Interface, Potently Inhibits Tumor Growth Across a Broad Panel of Tumor Models:
In recent years, HER3 has increasingly been implicated in the progression of a variety of tumor types and in acquired resistance to EGFR and HER2 therapies. Whereas EGFR and HER2 primarily signal through the MAPK pathway, HER3, as a heterodimer with EGFR or HER2, potently activates the PI3K pathway. Despite its critical role, previous attempts to target HER3 with neutralizing antibodies have shown disappointing efficacy in the clinic, most likely due to suboptimal and indirect mechanisms of action that fail to completely block heterodimerization; for example, tumors can escape inhibition of ligand binding by upregulating ligand-independent mechanisms of HER3 activation. We therefore developed 10D1F, a picomolar affinity, highly specific anti-HER3 neutralizing antibody that binds the HER3 heterodimerization interface, a region that was hitherto challenging to raise antibodies against. We demonstrate that 10D1F potently inhibits both EGFR:HER3 and HER2:HER3 heterodimerization to durably suppress activation of the PI3K pathway in a broad panel of tumor models. Even as a monotherapy, 10D1F shows superior inhibition of tumor growth in the same cell lines both in vitro and in mouse xenograft experiments, when compared with other classes of anti-HER3 antibodies. This includes models demonstrating ligand-independent activation of heterodimerization as well as constitutively activating mutations in the MAPK pathway. Possessing favorable pharmacokinetic and toxicologic profiles, 10D1F uniquely represents a new class of anti-HER3 neutralizing antibodies with a novel mechanism of action that offers significant potential for broad clinical benefit.
10D1F is a novel anti-HER3 antibody that uniquely binds the receptor dimerization interface to block ligand-dependent and independent heterodimerization with EGFR/HER2 and thus more potently inhibits tumor growth than existing anti-HER3 antibodies.
Medicine RSS-Feeds by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com
Πληροφορίες
Τρίτη 7 Ιανουαρίου 2020
10D1F, an Anti-HER3 Antibody that Uniquely Blocks the Receptor Heterodimerization Interface, Potently Inhibits Tumor Growth Across a Broad Panel of Tumor Models
Αναρτήθηκε από
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
στις
10:41 μ.μ.
Ετικέτες
00302841026182,
00306932607174,
alsfakia@gmail.com,
Anapafseos 5 Agios Nikolaos 72100 Crete Greece,
Medicine by Alexandros G. Sfakianakis,
Telephone consultation 11855 int 1193
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Αρχειοθήκη ιστολογίου
-
►
2023
(366)
- ► Φεβρουαρίου (184)
- ► Ιανουαρίου (182)
-
►
2022
(2814)
- ► Δεκεμβρίου (182)
- ► Σεπτεμβρίου (213)
- ► Φεβρουαρίου (264)
- ► Ιανουαρίου (262)
-
►
2021
(3815)
- ► Δεκεμβρίου (229)
- ► Σεπτεμβρίου (276)
- ► Φεβρουαρίου (64)
-
▼
2020
(5754)
- ► Δεκεμβρίου (401)
- ► Σεπτεμβρίου (365)
- ► Φεβρουαρίου (754)
-
▼
Ιανουαρίου
(894)
-
▼
Ιαν 07
(84)
- Medicine by Alexandros G. Sfakianakis,Anapafseos 5...
- Journals
- Journals
- Prognostic significance of lactate dehydrogenase i...
- A metanalysis on cabozantinib and bone metastases:...
- miR-7641 depletion suppresses proliferation of gas...
- Clinical efficacy of irinotecan plus raltitrexed c...
- A novel bis-aryl urea compound inhibits tumor prol...
- Combination treatment of bicalutamide and curcumin...
- Downregulation of lncRNA HOTTIP Suppresses the Pro...
- A pre-existing population of ZEB2 + quiescent cell...
- Efficacy of FGFR inhibitors and combination therap...
- 10D1F, an Anti-HER3 Antibody that Uniquely Blocks ...
- Regulatory T cell depletion alters the tumor micro...
- Characterization of Immune Dysfunction and Identif...
- Tumor Analyses Reveal Squamous Transformation and ...
- Racial Differences in the Association between Lumi...
- Multifactorial deep learning reveals pan-cancer ge...
- LncRNA MAGI2-AS3 Upregulates Cytokine Signaling 1 ...
- Phase I Study of Yttrium-90 Radiolabeled M5A Anti-...
- Risk factors and predictive model of diarrhoea amo...
- Microsurgical Management of Ventral Intradural-Ext...
- A multi-institutional analysis of factors influenc...
- Dissection of the vertebral artery fenestration li...
- Surgical Treatment of an Intracranial Anterior Eth...
- Transblepharo-preseptal modified orbitozygomatic a...
- Side-to-end hypoglossal-facial neurorrhaphy for tr...
- Topical antiseptics for chronic suppurative otitis...
- Molecular and clinical characterization of human a...
- Prevalence of NUT carcinoma in head and neck: Anal...
- The role of eosinophils in immunotherapy.
- Food allergy in adults in Europe: what can we lear...
- Association of SOX2, OCT4 and WNT5A Expression in ...
- The Rare Radiographic Sunburst Appearance of Odont...
- Subclinical nephrotoxicity in patients with beta-t...
- Amplitude Modulated Noise for Tinnitus Suppression...
- Noise-Induced Change of Cortical Temporal Processi...
- Clinical significance of chemokine receptor antago...
- Relationship between Movement Stereotype and Focus...
- Features of the Dynamics of the Human EEG Spectrum...
- Neurophysiological Features of Cognitive Activity ...
- Neuroglobin in Purkinje Neurons in the Rate Cerebe...
- Recurrent Necrotizing Soft Tissue Infections with ...
- YARS as an oncogenic protein that promotes gastric...
- In Search of the Long-Desired ‘Copernican Therapeu...
- GSE
- Psychometric Properties of the Spanish Version of ...
- Dravet syndrome: Treatment options and management ...
- SCN1A/NaV1.1 channelopathies: Mechanisms in expres...
- SCN2A channelopathies: Mechanisms and models
- Social Inequalities in Fertility in Women Residing...
- SCN1A‐related phenotypes: Epilepsy and beyond
- SCN8A encephalopathy: Mechanisms and models
- Dravet syndrome as part of the clinical and geneti...
- Dravet syndrome and other sodium channel‐related e...
- Phenotypic spectrum and genetics of SCN2A‐related ...
- Gerbode defect and left ventricular-aortic discont...
- Dravet syndrome: Early electroclinical findings an...
- Predicting the impact of sodium channel mutations ...
- Hyperlipidemia in patients newly treated with anti...
- Arnica montana and Bellis perennis for seroma redu...
- Determining the prevalence and severity of cancer ...
- Spatial patterns of tau deposition are associated ...
- Feasibility of ovine and porcine models for simula...
- Applying Machine Learning in Liver Disease & Trans...
- Liver‐on‐a‐Chip Models of Fatty Liver Disease
- Woolly hair: a rare disorder
- Evaluation of interleukin-18 and soluble interleuk...
- Idiopathic orbital inflammatory syndrome: a dermat...
- Relation between insulin resistance and severity o...
- Tranexamic acid versus topical mesolightening mixt...
- Mechanism of muscle–tendon–bone complex developmen...
- The relationship between the levels of interleukin...
- Efficacy of dermoscopy in the diagnosis of differe...
- Foreplay importance from the point of view of a sa...
- Correlation between squamous cell carcinoma antige...
- Treatment of a wide wound area with extensive necr...
- Skin disorders among elderly patients
- Functional Electrical Stimulation for Presbyphonia...
- Analysis of Abdominal Dermal‐Fat Grafting to Repai...
- Gingival recession behavior with immediate implant...
- Effect of proton pump inhibitors on high-dose meth...
- Archives of Mental Health
- Medicine by Alexandros G. Sfakianakis,Anapafseos 5...
-
▼
Ιαν 07
(84)
-
►
2019
(146)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου